FDA Approves Pancreatic Cancer Drug That Could Double Survival Time

FDA Approves Pancreatic Cancer Drug That Could Double Survival Time

💼 Finance & Business
Summary

Rasonque joins a short list of treatment options for one of the country’s deadliest types of cancer.

Visit the original source for the full article

🌐 Translate to:
More from 💼 Finance & Business →